Short Interest in iCoreConnect Inc. (NASDAQ:ICCT) Drops By 84.1%

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 40,600 shares, a decrease of 84.1% from the February 28th total of 254,700 shares. Based on an average daily volume of 794,400 shares, the short-interest ratio is presently 0.1 days. Approximately 2.4% of the shares of the stock are sold short.

Institutional Investors Weigh In On iCoreConnect

A hedge fund recently bought a new stake in iCoreConnect stock. Virtu Financial LLC purchased a new stake in iCoreConnect Inc. (NASDAQ:ICCT) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned 1.04% of iCoreConnect as of its most recent SEC filing. Institutional investors own 13.42% of the company’s stock.

iCoreConnect Price Performance

Shares of NASDAQ:ICCT traded down $0.03 during trading hours on Thursday, hitting $0.37. 705,408 shares of the company’s stock traded hands, compared to its average volume of 359,286. The company has a debt-to-equity ratio of 7.93, a quick ratio of 0.11 and a current ratio of 0.11. The company’s fifty day simple moving average is $1.60 and its two-hundred day simple moving average is $3.81. iCoreConnect has a 52 week low of $0.32 and a 52 week high of $35.80. The company has a market cap of $773,229.00, a price-to-earnings ratio of -0.01 and a beta of 1.09.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.